Epistaxis management on COVID-19–positive patients: Our early case experience and treatment

3Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Epistaxis management on COVID-19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with absorbable material to prevent COVID-19 transmission to surrounding healthcare workers.

Author supplied keywords

Cite

CITATION STYLE

APA

Bathula, S. S. R., Patrick, T., & Srikantha, L. (2020). Epistaxis management on COVID-19–positive patients: Our early case experience and treatment. Clinical Case Reports, 8(11), 2195–2198. https://doi.org/10.1002/ccr3.3137

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free